Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 22 Oct 2021 for 4D Molecular Therapeutics Inc., €308k. Read the official filing
Filing timeline
BuySaleDavid Schaffer
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
David Schaffer: trading record in brief
David Schaffer, listed as board member, appears in our data through filings on 4D Molecular Therapeutics, Inc. shares, published by SEC (Form 4). Between 27 September 2021 and 20 October 2021, the trades on record add up to 3 filings.
The open-market record consists of 3 sales worth €860k, with no purchase.
The newest entry dates from 22 October 2021: an open-market sale of €308k, in 4D Molecular Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Schaffer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
11,565 shares@ US$31.022135.8% of flowCommon StockSEC:0001567619-21-018628:0
7,806 shares@ US$27.992821.9% of flowCommon StockSEC:0001567619-21-017751:0
13,075 shares@ US$32.587142.3% of flowCommon StockSEC:0001567619-21-017624:0
3 of 3 declarations
